摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-1-hydroxyphenazine | 855375-09-6

中文名称
——
中文别名
——
英文名称
2-bromo-1-hydroxyphenazine
英文别名
2-bromophenazin-1-ol;2-Bromo-1-hydroxyphenazine
2-bromo-1-hydroxyphenazine化学式
CAS
855375-09-6
化学式
C12H7BrN2O
mdl
——
分子量
275.104
InChiKey
STQWXAYAYAVARZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    46
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-bromo-1-hydroxyphenazine碘甲烷potassium carbonate 作用下, 以 丙酮 为溶剂, 反应 3.02h, 以98%的产率得到2-bromo-1-methoxyphenazine
    参考文献:
    名称:
    Potential Chemopreventive Agents Based on the Structure of the Lead Compound 2-Bromo-1-hydroxyphenazine, Isolated from Streptomyces Species, Strain CNS284
    摘要:
    The isolation of 2-bromo-1-hydroxyphenazine from a marine Streptomyces species, strain CNS284, and its activity against NF-kappa B, suggested that a short and flexible route for the synthesis of this metabolite and a variety of phenazine analogues should be developed. Numerous phenazines were subsequently prepared and evaluated as inducers of quinone reductase I (QR1) and inhibitors of quinone reductase 2 (QR2), NF-kappa B, and inducible nitric oxide synthase (iNOS). Several of the active phenazine derivatives displayed IC50 values vs QR1 induction and QR2 inhibition in the nanomolar range, suggesting that they may find utility as cancer chemopreventive agents.
    DOI:
    10.1021/jm1011066
  • 作为产物:
    描述:
    1-羟基吩嗪N-溴代丁二酰亚胺(NBS) 作用下, 以 甲苯 为溶剂, 反应 8.0h, 以34%的产率得到2-bromo-1-hydroxyphenazine
    参考文献:
    名称:
    Potential Chemopreventive Agents Based on the Structure of the Lead Compound 2-Bromo-1-hydroxyphenazine, Isolated from Streptomyces Species, Strain CNS284
    摘要:
    The isolation of 2-bromo-1-hydroxyphenazine from a marine Streptomyces species, strain CNS284, and its activity against NF-kappa B, suggested that a short and flexible route for the synthesis of this metabolite and a variety of phenazine analogues should be developed. Numerous phenazines were subsequently prepared and evaluated as inducers of quinone reductase I (QR1) and inhibitors of quinone reductase 2 (QR2), NF-kappa B, and inducible nitric oxide synthase (iNOS). Several of the active phenazine derivatives displayed IC50 values vs QR1 induction and QR2 inhibition in the nanomolar range, suggesting that they may find utility as cancer chemopreventive agents.
    DOI:
    10.1021/jm1011066
点击查看最新优质反应信息

文献信息

  • Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis
    作者:Nicholas V. Borrero、Fang Bai、Cristian Perez、Benjamin Q. Duong、James R. Rocca、Shouguang Jin、Robert W. Huigens III
    DOI:10.1039/c3ob42416b
    日期:——

    We have discovered a novel class of bromophenazines with potent antibacterial activity against Staphylococcus aureus and Staphylococcus epidermidis.

    我们发现了一类新型的溴苯青霉素,对金黄色葡萄球菌和表皮葡萄球菌具有强有力的抗菌活性。
  • [EN] PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS<br/>[FR] DÉRIVÉS DE PHÉNAZINE COMME AGENTS ANTIMICROBIENS
    申请人:UNIV FLORIDA
    公开号:WO2015100331A3
    公开(公告)日:2015-09-03
  • PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS
    申请人:University of Florida Research Foundation, Inc.
    公开号:EP3086791A2
    公开(公告)日:2016-11-02
  • US9856225B2
    申请人:——
    公开号:US9856225B2
    公开(公告)日:2018-01-02
  • [EN] PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS<br/>[FR] DÉRIVÉS DE PHÉNAZINE UTILISÉS COMME AGENTS ANTIMICROBIENS
    申请人:UNIV FLORIDA
    公开号:WO2017011730A2
    公开(公告)日:2017-01-19
    The present invention provides novel phenazine derivatives, such as compounds of Formula (I') (e.g., Formula (I)), (II), and (III), and pharmaceutically acceptable salts thereof. The compounds of the invention are expected to be antimicrobial agents and may act by a microbial warfare strategy (e.g., a reactive oxygen species (ROS)-based competition strategy). The present invention also provides pharmaceutical compositions, kits, uses, and methods that involve the compounds of the invention and may be useful in preventing or treating a microbial infection (e.g., a bacterial infection or mycobacterial infection) in a subject, inhibiting the growth and/or reproduction of a microorganism (e.g., a bacterium or mycobacterium), killing a microorganism (e.g., a bacterium or mycobacterium), inhibiting the formation and/or growth of a biofilm, reducing or clearing a biofilm, and/or disinfecting a surface.
查看更多